The US gov­ern­ment said it will re­fer tele­health and GLP-1 com­pa­ny Hims & Hers to the Jus­tice De­part­ment for in­ves­ti­ga­tion, fol­low­ing the com­pa­ny's con­tro­ver­sial launch of a com­pound­ed ver­sion of No­vo Nordisk’s new­ly ap­proved weight loss pill...